Advice amendment on acid

The TGA's scheduling committee have recommended a change to the safety advice for azelaic acid Australian regulators have recommended altering the advice given to patients when using azelaic acid.   The Therapeutic Goods Administration (TGA) Advisory Committees on Medicines and Chemicals Scheduling has made an interim decision to amend the current scheduling of azelaic acid to